Insperity (NSP) Competitors $46.43 -0.59 (-1.25%) Closing price 03:59 PM EasternExtended Trading$46.40 -0.03 (-0.06%) As of 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NSP vs. CCRN, KFY, RHI, ASGN, MAN, HSII, BBSI, KFRC, KELYA, and TBIShould you be buying Insperity stock or one of its competitors? The main competitors of Insperity include Cross Country Healthcare (CCRN), Korn/Ferry International (KFY), Robert Half (RHI), ASGN (ASGN), ManpowerGroup (MAN), Heidrick & Struggles International (HSII), Barrett Business Services (BBSI), Kforce (KFRC), Kelly Services (KELYA), and TrueBlue (TBI). Insperity vs. Its Competitors Cross Country Healthcare Korn/Ferry International Robert Half ASGN ManpowerGroup Heidrick & Struggles International Barrett Business Services Kforce Kelly Services TrueBlue Insperity (NYSE:NSP) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment. Do analysts rate NSP or CCRN? Insperity currently has a consensus price target of $58.33, indicating a potential upside of 25.64%. Cross Country Healthcare has a consensus price target of $17.93, indicating a potential upside of 37.39%. Given Cross Country Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Cross Country Healthcare is more favorable than Insperity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Insperity 2 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.80Cross Country Healthcare 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Which has stronger valuation & earnings, NSP or CCRN? Insperity has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Insperity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInsperity$6.58B0.27$91M$1.0643.80Cross Country Healthcare$1.34B0.32-$14.56M-$0.26-50.19 Is NSP or CCRN more profitable? Insperity has a net margin of 0.60% compared to Cross Country Healthcare's net margin of -0.70%. Insperity's return on equity of 35.32% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Insperity0.60% 35.32% 1.84% Cross Country Healthcare -0.70%1.72%1.24% Which has more volatility & risk, NSP or CCRN? Insperity has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500. Do insiders and institutionals believe in NSP or CCRN? 93.4% of Insperity shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 5.3% of Insperity shares are owned by company insiders. Comparatively, 4.9% of Cross Country Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media refer more to NSP or CCRN? In the previous week, Cross Country Healthcare had 2 more articles in the media than Insperity. MarketBeat recorded 7 mentions for Cross Country Healthcare and 5 mentions for Insperity. Cross Country Healthcare's average media sentiment score of 0.69 beat Insperity's score of 0.45 indicating that Cross Country Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Insperity 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cross Country Healthcare 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryInsperity beats Cross Country Healthcare on 10 of the 16 factors compared between the two stocks. Get Insperity News Delivered to You Automatically Sign up to receive the latest news and ratings for NSP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NSP vs. The Competition Export to ExcelMetricInsperityStaffing IndustryBusiness SectorNYSE ExchangeMarket Cap$1.77B$1.40B$20.63B$21.91BDividend Yield5.10%3.77%2.89%3.62%P/E Ratio43.8023.6326.6030.12Price / Sales0.274.451,885.0466.99Price / Cash13.027.9131.8224.26Price / Book17.933.398.224.70Net Income$91M$30.46M$196.57M$1.01B7 Day Performance-2.91%-1.76%-0.38%-0.44%1 Month Performance-10.65%-2.46%4.80%1.45%1 Year Performance-47.61%-20.92%53.13%15.02% Insperity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NSPInsperity4.7642 of 5 stars$46.43-1.3%$58.33+25.6%-47.0%$1.77B$6.58B43.804,500CCRNCross Country Healthcare3.4846 of 5 stars$12.50+7.9%$17.93+43.4%+5.9%$379.71M$1.34B-48.088,205News CoverageKFYKorn/Ferry International4.638 of 5 stars$69.44+2.2%$81.00+16.6%-3.9%$3.56B$2.76B14.749,253Positive NewsRHIRobert Half4.9101 of 5 stars$32.12+2.4%$45.00+40.1%-51.8%$3.19B$5.80B18.3514,700Trending NewsAnalyst ForecastASGNASGN3.8784 of 5 stars$46.94+3.4%$60.00+27.8%-51.0%$1.99B$4.10B14.853,200Upcoming EarningsAnalyst ForecastMANManpowerGroup4.5073 of 5 stars$38.02flat$46.40+22.0%-47.5%$1.76B$17.85B-100.0526,700News CoverageUpcoming EarningsAnalyst ForecastHSIIHeidrick & Struggles International2.8406 of 5 stars$58.21+0.0%$59.00+1.4%+53.4%$1.21B$1.12B36.612,201BBSIBarrett Business Services4.7741 of 5 stars$42.85+0.4%$47.00+9.7%+16.0%$1.10B$1.14B21.113,658Analyst ForecastKFRCKforce3.9096 of 5 stars$27.95+0.5%$48.67+74.1%-49.9%$519.84M$1.36B10.4312,000News CoverageAnalyst ForecastKELYAKelly Services4.5212 of 5 stars$12.31-1.0%$25.00+103.1%-39.4%$438.53M$4.33B-61.554,200News CoverageTBITrueBlue3.0484 of 5 stars$5.59+0.7%$8.00+43.2%-23.3%$165.95M$1.57B-4.864,200Positive News Related Companies and Tools Related Companies CCRN Competitors KFY Competitors RHI Competitors ASGN Competitors MAN Competitors HSII Competitors BBSI Competitors KFRC Competitors KELYA Competitors TBI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NSP) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insperity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insperity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
